Targeting Skin Carcinogenesis with a New Antitumor therapy: Preclinical Validation hematological and biochemistry studies
Mohammed, E., Khamis, A., ElHefnawi, M., Salim, E. (2025). Targeting Skin Carcinogenesis with a New Antitumor therapy: Preclinical Validation hematological and biochemistry studies. EKB Journal Management System, 51(1), 64-77. doi: 10.21608/djs.2025.397141.1218
Esraa M. Mohammed; Abeer A. Khamis; Mahmoud ElHefnawi; Elsayed I. Salim. "Targeting Skin Carcinogenesis with a New Antitumor therapy: Preclinical Validation hematological and biochemistry studies". EKB Journal Management System, 51, 1, 2025, 64-77. doi: 10.21608/djs.2025.397141.1218
Mohammed, E., Khamis, A., ElHefnawi, M., Salim, E. (2025). 'Targeting Skin Carcinogenesis with a New Antitumor therapy: Preclinical Validation hematological and biochemistry studies', EKB Journal Management System, 51(1), pp. 64-77. doi: 10.21608/djs.2025.397141.1218
Mohammed, E., Khamis, A., ElHefnawi, M., Salim, E. Targeting Skin Carcinogenesis with a New Antitumor therapy: Preclinical Validation hematological and biochemistry studies. EKB Journal Management System, 2025; 51(1): 64-77. doi: 10.21608/djs.2025.397141.1218